Alliance Wealth Advisors (Utah)’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Alliance Wealth Advisors (Utah)'s HALO Position: Q2 2026 in Review
Alliance Wealth Advisors (Utah) reduced its Halozyme (HALO) stake by 17% in Q2 2026, selling an estimated $105K and leaving 7,802 shares worth $611K. The position accounts for 0.12% of the portfolio, ranked #110.
Alliance Wealth Advisors (Utah) first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.32M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Alliance Wealth Advisors (Utah) held 7,802 shares of Halozyme worth $611K as of Q2 2026.
- Alliance Wealth Advisors (Utah) sold 1,542 Halozyme shares in Q2 2026, an estimated $105K.
- Halozyme made up 0.12% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #110 holding.
- Alliance Wealth Advisors (Utah) first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
- Alliance Wealth Advisors (Utah)'s Halozyme position peaked at $1.32M in Q3 2025.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.